Advanced search
Publication Cover
Hematology Volume 23, 2018 - Issue 8
Submit an article Journal homepage
1,058
Views
9
CrossRef citations to date
0
Altmetric
Hematological Malignancy

Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients

Ming MaClinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
,
Riyang ZhaoResearch Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
,
Xingxiao YangDepartment of Infection Management, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
,
Lianmei ZhaoResearch Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
,
Lihua LiuDepartment of Biotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
,
Cong ZhangResearch Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
,
Xuexiao WangDepartment of Biotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
&
Baoen ShanResearch Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 448-455 | Published online: 08 Feb 2018

References

  • Lee S, Day NS, Miles RR, et al. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a children’s oncology group report. Br J Haematol. 2017;177:601–611. doi: 10.1111/bjh.14604
  • Ma M, Zhao LM, Sun GG, et al. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs. Oncol Rep. 2016;35:3122–3130. doi: 10.3892/or.2016.4622
  • Yang BX, Duan YJ, Dong CY, et al. Novel functions for mda-7/IL-24 and IL-24 delE5: regulation of differentiation of acute myeloid leukemic cells. Mol Cancer Ther. 2011;31:615–625. doi: 10.1158/1535-7163.MCT-10-0863
  • Dong CY, Zhang F, Duan YJ, et al. Mda-7/IL-24 inhibits the proliferation of hematopoietic malignancies in vitro and in vivo. Exp Hematol. 2008;36:938–946. doi: 10.1016/j.exphem.2008.03.009
  • Hosseini E, Hosseini SY, Hashempour T, et al. Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line. Mol Med Rep. 2017;15:495–501. doi: 10.3892/mmr.2016.6009
  • Huo W, Li ZM, Zhu XM, et al. MDA-7/IL-24 suppresses tumor adhesion and invasive potential in hepatocellular carcinoma cell lines. Oncol Rep. 2013;30:986–992. doi: 10.3892/or.2013.2507
  • Ma M, Yang XX, Zhao LM, et al. Mda-7/IL-24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway. Mol Med Rep. 2017;15:5633–5642. doi: 10.3892/mmr.2017.7306
  • Liu X, Zhou H, Huang X, et al. A broad blockade of signaling from the IL-20 family of cytokines potently attenuates collagen-induced arthritis. J Immunol. 2016;197:3029–3037. doi: 10.4049/jimmunol.1600399
  • Liu W, Wu M, Huang Z, et al. C-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish. Leukemia. 2017;31:222–233. doi: 10.1038/leu.2016.170
  • Piovesan D, Tempany J, Di-pietro A, et al. C-myb regulates the T-Bet-dependent differentiation program in B cells to coordinate antibody responses. Oncotarget 2015;6:36928–36938.
  • Yan F, Bai LF, Gao H, et al. EGF reverses multi-drugs resistance via the p-ERK pathway in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models. Cell Rep. 2017;19:461–470. doi: 10.1016/j.celrep.2017.04.022
  • Jaffe ES. The WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009;2009:523–531.
  • Zelenetz AD, Gordon LI, WlerdaI WG, et al. Non-Hodgkin’s lymphomas, version 4.2014. J Natl Compr Canc Netw. 2014;12:1282–1303. doi: 10.6004/jnccn.2014.0125
  • Chen S, Wang Z, Dai X, et al. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating C-myb in vitro. Cancer Sci. 2013;104:826–834. doi: 10.1111/cas.12156
  • Lin KI, Kao YY, Kuo HK, et al. Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1. J Biol Chem. 2006;81:24111–24123. doi: 10.1074/jbc.M601106200
  • Xu SL, Oshima T, Imada T, et al. Stabilization of MDA-7/IL-24 for colon cancer therapy. Cancer Lett. 2013;335:421–430. doi: 10.1016/j.canlet.2013.02.055
  • Patani N, Jones AD, Mansel R, et al. Tumour suppressor function of MDA-7/IL-24 in human breast cancer. Cancer Cell Int. 2010;10:29.
  • Cheng HR, Wu BQ, Chen L, et al. Expression and effect of serum interleukin-24 level on bone marrow mononuclear cells in children with acute leukemia. Genet Mol Res. 2015;14:17281–17288. doi: 10.4238/2015.December.16.28
  • Galimova E, Ratsep R, Traks T, et al. Interleukin-10 family cytokines pathway: genetic variants and psoriasis. Br J Dermatol. 2017;176:1577–1587. doi: 10.1111/bjd.15363
  • Chan YH, Chiang MF, Tsai YC, et al. Absence of the transcriptional repressor blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J Immunol. 2009;183:7039–7046. doi: 10.4049/jimmunol.0901543
  • Pradhan AK, Talukdar S, Bhoopathi P, et al. Mda-7/IL-24 mediates cancer cell-specific death via regulation of miR-221 and the beclin-1 axis. Cancer Res. 2017;77:949–959. doi: 10.1158/0008-5472.CAN-16-1731
  • Ma YF, Ren Y, Wu CJ, et al. Interleukin [IL]-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer. Mol Immunol. 2016;75:11–20. doi: 10.1016/j.molimm.2016.05.010
  • Lv C, Su Q, Liang Y, et al. Oncolytic vaccine virus harbouring the IL-24 gene suppresses the growth of lung cancer by inducing apoptosis. Biochem Biophys Res Commun. 2016;476:21–28. doi: 10.1016/j.bbrc.2016.05.088

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.